Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Psychother Res ; 32(5): 663-677, 2022 06.
Artículo en Inglés | MEDLINE | ID: mdl-34763613

RESUMEN

While agreement between clients and their clinicians on therapy goals has frequently been investigated as a process-level variable (i.e., working alliance), dyadic convergence on presenting concerns is also important for initial case formulation. Transdiagnostic presenting problems, like sleep difficulty, pose a particular challenge for client-therapist convergence. The current study describes sleep difficulty in a treatment-seeking college population and investigates the impact of client and therapist baseline sleep problem reports on therapy outcomes.Data were collected through a large practice research network, with the sample comprising 47,023 clients from 99 university counseling centers across the United States.A larger proportion of clients (49.3%) had self-reported high baseline sleep difficulty than those with a clinician-identified sleep concern (16.0%). Clients with baseline sleep difficulty were more likely to end treatment with greater self-reported sleep difficulty and psychological symptom distress, although they may experience larger gross symptom change than clients without baseline sleep difficulty. Clinician-identified sleep concerns were significantly associated with client outcomes, particularly when clients did not report baseline sleep difficulty themselves.Findings from this study suggest that it may be efficacious and efficient with limited time for treatment to address sleep concerns in a college setting.Clinicians' attendance to their clients' transdiagnostic presenting concerns, like sleep difficulty, may increase clients' own awareness of problematic patterns of behavior. When time for therapy is short, as is often the case in college counseling, it may be efficient to prioritize these concerns with the potential to impact a broad range of symptoms.


Asunto(s)
Relaciones Profesional-Paciente , Trastornos del Sueño-Vigilia , Consejo , Humanos , Autoinforme , Resultado del Tratamiento
2.
J Clin Psychopharmacol ; 36(3): 262-71, 2016 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-27043118

RESUMEN

This prospective 12-week open-label trial evaluates the tolerability and efficacy of memantine hydrochloride for the treatment of core social and cognitive deficits in adults with high-functioning autism spectrum disorder (ASD). Measures for assessment of therapeutic response included the Social Responsiveness Scale-Adult Research Version (SRS-A), disorder-specific Clinical Global Impression scales, Behavior Rating Inventory of Executive Functioning-Adult Self-Report, Diagnostic Analysis of Nonverbal Accuracy Scale, and Cambridge Neuropsychological Test Automated Battery. Eighteen adults (mean age, 28 ± 9.5 years) with high-functioning ASD (SRS-A raw score, 99 ± 17) were treated with memantine (mean dose, 19.7 ± 1.2 mg/d; range, 15-20 mg), and 17 (94%) completed the trial. Treatment with memantine was associated with significant reduction on informant-rated (SRS-A, -28 ± 25; P < 0.001) and clinician-rated (Clinical Global Impression-Improvement subscale ≤2, 83%) measures of autism severity. In addition, memantine treatment was associated with significant improvement in ADHD and anxiety symptom severity. Significant improvement was noted in nonverbal communication on the Diagnostic Analysis of Nonverbal Accuracy Scale test and in executive function per self-report (Behavior Rating Inventory of Executive Functioning-Adult Self-Report Global Executive Composite, -6 ± 8.8; P < 0.015) and neuropsychological assessments (Cambridge Neuropsychological Test Automated Battery). Memantine treatment was generally well tolerated and was not associated with any serious adverse events. Treatment with memantine appears to be beneficial for the treatment of ASD and associated psychopathology and cognitive dysfunction in intellectually capable adults. Future placebo-controlled trials are warranted.


Asunto(s)
Trastorno del Espectro Autista/tratamiento farmacológico , Trastorno del Espectro Autista/epidemiología , Antagonistas de Aminoácidos Excitadores/uso terapéutico , Memantina/uso terapéutico , Trastorno de la Conducta Social/tratamiento farmacológico , Trastorno de la Conducta Social/epidemiología , Adolescente , Adulto , Trastorno del Espectro Autista/diagnóstico , Femenino , Humanos , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Trastorno de la Conducta Social/diagnóstico , Resultado del Tratamiento , Adulto Joven
3.
Rehabil Psychol ; 66(3): 300-310, 2021 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-34472927

RESUMEN

Purpose: Campus counseling centers, which oversee the provision of mental health services, can play a vital role in supporting positive outcomes among college students in general; however, little remains known about the effectiveness of campus-based counseling for reducing academic and psychological distress among college students with disabilities. The purpose of the current study was to examine the effectiveness of individual campus-based counseling for students with disabilities and to determine whether the effectiveness of counseling varied by student disability status. Method: Data for the present study were gathered by the Center for Collegiate Mental Health from the 2016-2019 academic years. Participants consisted of help-seeking students with only psychiatric disabilities (n = 643), students with disabilities other than only psychiatric disabilities (n = 3,833), and students without a disability (n = 54,576). Results: Results indicated that students with disabilities demonstrated significantly fewer reductions in levels of psychological and academic distress than their nondisabled peers, and analyses further revealed variation by disability type. Conclusions: These findings advance our understanding of the effectiveness of campus counseling services for improving pertinent outcomes among help-seeking college students with disabilities. Implications for clinical practice, theory, and future research are discussed. (PsycInfo Database Record (c) 2021 APA, all rights reserved).


Asunto(s)
Personas con Discapacidad , Servicios de Salud Mental , Consejo , Humanos , Estudiantes , Universidades
4.
J Autism Dev Disord ; 48(9): 3101-3115, 2018 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-29675767

RESUMEN

To assess prevalence and severity of emotional dysregulation (ED) in psychiatrically referred youth with autism spectrum disorder (ASD). ASD youth (N = 123) were compared to youth with attention-deficit/hyperactivity disorder (ADHD) and controls. The majority of psychiatrically referred youth with ASD had positive Child Behavior Checklist-ED (CBCL-ED) profile that was significantly higher than in youth with ADHD (82 vs. 53%; p < 0.001). The severe emotional dysregulation (SED) profile was significantly greater in ASD youth than ADHD (44 vs. 15%; p < 0.001). In the presence of SED profile ASD youth suffered from greater severity of autism, associated psychopathology, and psychosocial dysfunction. Greater than expected prevalence of SED in psychiatrically referred youth with ASD that identifies distinct clinical correlates associated with severe morbidity and dysfunction.


Asunto(s)
Síntomas Afectivos/epidemiología , Síntomas Afectivos/psicología , Trastorno del Espectro Autista/epidemiología , Trastorno del Espectro Autista/psicología , Derivación y Consulta , Índice de Severidad de la Enfermedad , Adolescente , Síntomas Afectivos/diagnóstico , Atención Ambulatoria/métodos , Trastorno por Déficit de Atención con Hiperactividad/diagnóstico , Trastorno por Déficit de Atención con Hiperactividad/epidemiología , Trastorno por Déficit de Atención con Hiperactividad/psicología , Trastorno del Espectro Autista/diagnóstico , Niño , Preescolar , Femenino , Humanos , Masculino , Factores de Riesgo , Adulto Joven
SELECCIÓN DE REFERENCIAS
Detalles de la búsqueda